"全球益生菌解決方案專家 功能益生菌領導者"

During the past decade, Glac Biotech Co., Ltd conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Glac Biotech Co., Ltd" are "Alzheimer Disease" (1 trials), "Atopic Dermatitis" (1 trials), "Chronic Obstructive Pulmonary Disease" (1 trials), "Oral Health" (1 trials) and "Probiotic Metabolites" (1 trials). Many other conditions were trialed in "Glac Biotech Co., Ltd" in a lesser frequency.

Most popular intervention types in "Glac Biotech Co., Ltd" are "Dietary Supplement" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Bifidobacterium animalis subsp. lactis CP-9" (1 trials), "Bifidobacterium longum CCFM1029" (1 trials), "Combined heat-killed probiotics (1)" (1 trials) and "Combined heat-killed probiotics (2)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Glac Biotech Co., Ltd" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Glac Biotech Co., Ltd". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Glac Biotech Co., Ltd, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Glac Biotech Co., Ltd, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".